MetaADEDB 2.0 @ LMMD
Ropivacaine
(NDNSIBYYUOEUSV-RSAXXLAASA-N)
Structure
SMILES
CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C.Cl
Molecular Formula:
C17H27ClN2O
Molecular Weight:
310.862
Log P:
4.3193
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
32.34
CAS Number(s):
98717-15-8; 132112-35-7
Synonym(s)
1.
Ropivacaine
2.
1-Propyl-2',6'-pipecoloxylidide
3.
AL 381
4.
AL-381
5.
LEA 103
6.
LEA-103
7.
Naropeine
8.
Naropin
9.
Ropivacaine Hydrochloride
10.
Ropivacaine Monohydrochloride
11.
Ropivacaine Monohydrochloride, (S)-isomer
12.
1 Propyl 2',6' pipecoloxylidide
13.
AL381
14.
LEA103
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Incorrect dose administeredFAERS: 21US FAERS
2Suspected product quality issueFAERS: 20US FAERS
3Therapeutic product effect prolongedFAERS: 20US FAERS
4ArthropathyFAERS: 18US FAERS
5Toxicity to various agentsFAERS: 7US FAERS
6BradycardiaFAERS: 5US FAERS
7Sinus TachycardiaFAERS: 5US FAERS
8Cardiac ArrestFAERS: 4US FAERS
9Chest PainFAERS: 4US FAERS
10Drug ineffectiveFAERS: 4US FAERS
11ParesisFAERS: 4US FAERS
12TachycardiaFAERS: 4US FAERS
13DiplegiaFAERS: 3US FAERS
14PainFAERS: 3US FAERS
15Phrenic nerve paralysisFAERS: 3US FAERS
16Respiratory distressFAERS: 3US FAERS
17AphoniaFAERS: 2US FAERS
18Atrial FibrillationFAERS: 2US FAERS
19Depressed Level of ConsciousnessFAERS: 2US FAERS
20HeadacheFAERS: 2US FAERS
21HypercapniaFAERS: 2US FAERS
22Incorrect route of drug administrationFAERS: 2US FAERS
23Medication ErrorFAERS: 2US FAERS
24OverdoseFAERS: 2US FAERS
25StridorFAERS: 2US FAERS
26AmaurosisFAERS: 1US FAERS
27AmputationFAERS: 1US FAERS
28ApathyFAERS: 1US FAERS
29AstheniaFAERS: 1US FAERS
30CardiotoxicityFAERS: 1US FAERS
31Chest discomfortFAERS: 1US FAERS
32CyanosisFAERS: 1US FAERS
33DisorientationFAERS: 1US FAERS
34DizzinessFAERS: 1US FAERS
35Drug ToleranceFAERS: 1US FAERS
36Drug level above therapeuticFAERS: 1US FAERS
37Drug toxicityFAERS: 1US FAERS
38HemiplegiaFAERS: 1US FAERS
39Hypertensive crisisFAERS: 1US FAERS
40Maternal exposure during deliveryFAERS: 1US FAERS
41MonoparesisFAERS: 1US FAERS
42MonoplegiaFAERS: 1US FAERS
43Muscle tightnessFAERS: 1US FAERS
44Myocardial InfarctionFAERS: 1US FAERS
45NauseaFAERS: 1US FAERS
46Nerve BlockFAERS: 1US FAERS
47PallorFAERS: 1US FAERS
48ParaparesisFAERS: 1US FAERS
49Peripheral motor neuropathyFAERS: 1US FAERS
50Peripheral nerve palsyFAERS: 1US FAERS
51Physical product label issueFAERS: 1US FAERS
52Product compounding quality issueFAERS: 1US FAERS
53Product quality issueFAERS: 1US FAERS
54PruritusFAERS: 1US FAERS
55QuadriparesisFAERS: 1US FAERS
56RadiculopathyFAERS: 1US FAERS
57Respiratory DepressionFAERS: 1US FAERS
58Respiratory FailureFAERS: 1US FAERS
59RestlessnessFAERS: 1US FAERS
60Sensorimotor disorderFAERS: 1US FAERS
61ShockFAERS: 1US FAERS
62SomnolenceFAERS: 1US FAERS
63TremorFAERS: 1US FAERS
64Unresponsive to stimuliFAERS: 1US FAERS
65Vocal Cord ParalysisFAERS: 1US FAERS
66Wrong technique in drug usage processFAERS: 1US FAERS
67nervous system disorderFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.